Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Uppsala, Sweden, 16 January 2018: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The... Read more
Gyros Protein Technologies becomes distributor of iLite® cell-based reporter gene assays for drug development Uppsala and Malmö, Sweden, 11 October 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has signed a distribution agreement withEuro Diagnostica, the full service assay solution company.... Read more
Developed to support assay development and validation for detection of anti-drug antibodies Uppsala, Sweden, June 29th, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market. ... Read more
Uppsala, Sweden, May 10, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its Gyrolab™ Protein A Kit. The new Protein A Kit offers increased efficiency and throughput for quantification of residual Protein A ligands, with 96... Read more
Uppsala, Sweden, 4 May, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Mark Vossenaar as Vice President Sales, Europe, effective immediately. Mr. Vossenaar brings more than 25 years of experience in developing and leading life and health science commercial... Read more
Agreement includes exclusive distribution of PurePep Coupling Agents in North America Uppsala, Sweden, 25 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim®... Read more
Uppsala, Sweden, 19 January 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his... Read more